MXPA03004907A - Uso de pirazolo (4,3-d) pirimidinas. - Google Patents

Uso de pirazolo (4,3-d) pirimidinas.

Info

Publication number
MXPA03004907A
MXPA03004907A MXPA03004907A MXPA03004907A MXPA03004907A MX PA03004907 A MXPA03004907 A MX PA03004907A MX PA03004907 A MXPA03004907 A MX PA03004907A MX PA03004907 A MXPA03004907 A MX PA03004907A MX PA03004907 A MXPA03004907 A MX PA03004907A
Authority
MX
Mexico
Prior art keywords
pyrazolo
pyrimidines
Prior art date
Application number
MXPA03004907A
Other languages
English (en)
Inventor
Eggenweiler Hans-Michael
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of MXPA03004907A publication Critical patent/MXPA03004907A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Virology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Psychiatry (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Hospice & Palliative Care (AREA)
  • AIDS & HIV (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
MXPA03004907A 2000-12-05 2001-11-09 Uso de pirazolo (4,3-d) pirimidinas. MXPA03004907A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10060388A DE10060388A1 (de) 2000-12-05 2000-12-05 Verwendung von Pyrazolo [4,3-d]pyrimidinen
PCT/EP2001/013036 WO2002045716A1 (de) 2000-12-05 2001-11-09 Verwendung von pyrazolo[4,3-d]pyrimidinen

Publications (1)

Publication Number Publication Date
MXPA03004907A true MXPA03004907A (es) 2003-09-05

Family

ID=7665844

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA03004907A MXPA03004907A (es) 2000-12-05 2001-11-09 Uso de pirazolo (4,3-d) pirimidinas.

Country Status (17)

Country Link
US (1) US20040023991A1 (es)
EP (1) EP1339410A1 (es)
JP (1) JP2004523493A (es)
KR (1) KR20030055338A (es)
CN (1) CN1479619A (es)
AU (1) AU2002216033A1 (es)
BR (1) BR0115911A (es)
CA (1) CA2436916A1 (es)
CZ (1) CZ20031752A3 (es)
DE (1) DE10060388A1 (es)
HU (1) HUP0302645A3 (es)
MX (1) MXPA03004907A (es)
PL (1) PL361890A1 (es)
RU (1) RU2003119546A (es)
SK (1) SK8072003A3 (es)
WO (1) WO2002045716A1 (es)
ZA (1) ZA200305181B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19942474A1 (de) * 1999-09-06 2001-03-15 Merck Patent Gmbh Pyrazolo[4,3-d]pyrimidine
ATE478872T1 (de) * 2002-03-28 2010-09-15 Ustav Ex Botan Av Cr V V I I O Pyrazoloä4,3-düpyrimidine, verfahren zu ihrer herstellung und therapeutische anwendung
KR100468352B1 (ko) * 2002-09-24 2005-01-27 한국과학기술연구원 신규 피라졸로피리미딘계 유도체, 그의 제조방법 및 이를 유효성분으로 하는 약학적 조성물
ATE475421T1 (de) * 2003-05-06 2010-08-15 Ustav Ex Botan Akademie Ved Ce Pyrazoloä4,3-düpyrimidines, verfahren zur ihre herstellung und deren verwendung
CA2711777A1 (en) * 2008-01-11 2009-08-13 Natco Pharma Limited Novel pyrazolo [3,4-d] pyrimidine derivatives as anti-cancer drugs
KR20210034623A (ko) * 2018-07-20 2021-03-30 메르크 파텐트 게엠베하 다발성 경화증의 치료 및 예방을 위한 방법에서 사용하기 위한 치환된 아미노-피리미딘 화합물

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1530747A (en) * 1976-04-05 1978-11-01 Massachusetts Inst Technology Pharmaceutical composition
US5858694A (en) * 1997-05-30 1999-01-12 Cell Pathways, Inc. Method for identifying compounds for inhibition of cancerous lesions
CA2238283C (en) * 1997-05-30 2002-08-20 Cell Pathways, Inc. Method for identifying compounds for inhibition of neoplastic lesions, pharmaceutical compositions from such compounds and uses of such compounds and compositions for treating neoplastic lesions

Also Published As

Publication number Publication date
WO2002045716A1 (de) 2002-06-13
PL361890A1 (en) 2004-10-04
RU2003119546A (ru) 2004-12-27
CA2436916A1 (en) 2002-06-13
SK8072003A3 (en) 2003-10-07
CN1479619A (zh) 2004-03-03
CZ20031752A3 (cs) 2003-10-15
HUP0302645A2 (hu) 2003-11-28
BR0115911A (pt) 2004-02-25
HUP0302645A3 (en) 2005-05-30
JP2004523493A (ja) 2004-08-05
ZA200305181B (en) 2004-10-04
EP1339410A1 (de) 2003-09-03
KR20030055338A (ko) 2003-07-02
US20040023991A1 (en) 2004-02-05
DE10060388A1 (de) 2002-06-06
AU2002216033A1 (en) 2002-06-18

Similar Documents

Publication Publication Date Title
AP2002002456A0 (en) Pyrazolo '4,3-d pyrimidine derivatives
EG24399A (en) Pyrrolo[2,3-D]pyrimidine compounds
IL159832A0 (en) 4-amino-6-phenyl-pyrrolo[2,3-d] pyrimidine derivatives
ZA994003B (en) Pyrrolo[2,3-d]pyrimidine compounds.
HRP20020798A2 (en) 5-ALKYLPYRIDO[2,3-d]PYRIMIDINES TYROZINE KINASE INHIBITORS
IL152771A0 (en) PYRROLO(2,3-d) PYRIMIDINE COMPOUNDS AS IMMUNOSUPPRESSIVE AGENTS
PL353366A1 (en) Pyrazolo[4,3-d]pyrimidines
PL358551A1 (en) 5-aminoalkyl-pyrazolo[4,3-d]pyrimidines
AU2001279700A1 (en) 5-aminoalkyl-pyrazolo(4,3-d)pyrimidines with a phosphodiesterase v-inhibiting effect
MXPA03004498A (es) Uso de pirazolo (4,3-d)pirimidinas.
MXPA03004907A (es) Uso de pirazolo (4,3-d) pirimidinas.
AU2001285785A1 (en) 2-aminoalkyl-thieno[2,3-d]pyrimidines
AU8578501A (en) 2-aminoalkyl-thieno(2,3-d)pyrimidines
PL361915A1 (en) Substituted 3.4-dihydro-pyrido[1,2-a]pyrimidines
AU2002210526A1 (en) Substituted 3.4-dihydro-pyrido[1,2-A]pyrimidines
PL361777A1 (en) Substituted 3.4-dihydro-pyrimido[1,2-a]pyrimidines and 3.4-dihydropyrazino[1,2-a]pyrimidines
SI1210349T1 (en) PYRAZOLO 4,3-d)PYRIMIDINES
ZA200202763B (en) Pyrazolo [4,3-D] pyrimidine derivatives.
ZA994004B (en) Pyrrolo[2,3-d]pyrimidine compounds.
ZA200106161B (en) Process for the preparation of pyrazolo[4,3-d]pyrimidin-7-one compounds and intermediates thereof.